Kamada ^{For Profit}

Kamada Pharmaceuticals is a global biopharmaceutical company that focuses on specialty plasma-derived therapeutics. They have a diverse portfolio of marketed products, a robust development pipeline, and industry-leading manufacturing capabilities. The company is committed to producing high-quality pharmaceuticals. They have a proprietary platform technology and know-how that allows them to extract and purify protein therapeutics from human plasma. Kamada's Inhaled AAT has the potential to become a transformational next-generation augmentation therapy for Alpha-1 Antitrypsin Deficiency patients. The company is also committed to Alpha-1 Patients and supporting the prevention of CMV disease after solid organ transplantation. Contact_info: N/A.